CEREBROLYSIN AS AN EARLY ADD-ON TO REPERFUSION THERAPY: TIME-TO-EVENT ANALYSIS OF THE CEREHETIS TRIAL

Authors
Category Systematic review
Conference16th World Stroke Congress
Year 2024
This article has no abstract
Epistemonikos ID: 3df946a0477ae0b2d33a5614cc1945c12ed85de1
First added on: Jan 10, 2026